Cognizant Technology Solutions CTSH is scheduled to report its fourth-quarter 2024 results on Feb. 05. The Zacks Consensus ...
and user acceptanc Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even ...